Summary: Carolina Liquid Chemistries (CLC) has partnered with Medline Industries to distribute an FDA-cleared fentanyl urine detect test kit that enhances access to rapid fentanyl screening in clinical laboratories and point-of-care sites nationwide.
Takeaways:
- Rapid Fentanyl Detection: The Fentanyl Urine Detect test kit provides qualitative detection of fentanyl in human urine with a low cutoff concentration of 1.0 ng/mL, delivering results in under six minutes, aiding in the fight against the opioid epidemic.
- Integration with RYAN Analyzer: The test kit works with CLC’s RYAN immunofluorescence analyzer, offering easy operation and providing printable, chartable results that can be interfaced with laboratory information systems for better data management.
- Strategic Distribution Agreement: By partnering with Medline Industries, a medical supply distributor, Carolina Liquid Chemistries aims to make the fentanyl screening test widely available across various healthcare settings, addressing the growing need for rapid and accurate drug testing solutions.
Carolina Liquid Chemistries (CLC) has entered into a distribution agreement with Medline Industries to make the FDA-cleared, point-of-care fentanyl screening test kit readily available to many point-of-care sites and clinical laboratories across the United States of America.
Medline, a medical supply manufacturer, distributor, and solutions provider, has more than 38,000 employees worldwide to serve healthcare providers across the continuum of care.
“This is a great opportunity for Medline to be part of the solution to the drug crisis in America,” says Nicole Krpan, Medline Laboratories division general manager. “The opioid epidemic, exacerbated by the potency of fentanyl, claims countless lives every day. With its low cutoff and rapid results, this test offers a new weapon in the fight against the effects of fentanyl.”
The Fentanyl Urine Detect Test Kit
The test kit, called Fentanyl Urine Detect, is intended for the qualitative detection of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL with a result in under six minutes. The test is used in conjunction with Carolina Liquid Chemistries’ RYAN immunofluorescence analyzer and can produce a printed, chartable result that is interfaceable with laboratory information systems (LIS). The test provides a preliminary result; a more specific alternative chemical method must be used in order to obtain a confirmed analytical result.
“The RYAN is easy to use and produces a printable, objective result which avoids the subjectivity associated with human interpretation,” says Philip Shugart, CEO of Carolina Liquid Chemistries. “It’s great to get a chartable result in only six minutes.”The RYAN analyzer is a fluorescence instrument for in vitro diagnostic tests on clinical urine specimens. Weighing less than five pounds, this portable analyzer can be used in a laboratory or in a point-of-care setting. To learn more about Fentanyl Urine Detect on the immunofluorescence.
Photo: CLC
